Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

165 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-27

Study Completion Date

2025-09-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching goal of the proposed study is to provide information which can lead to effective implementation of cessation support in the care of smokers diagnosed with lung or head \& neck cancer.

To achieve these aims, the study propose to conduct a longitudinal cohort study of patients diagnosed with lung or head \& neck cancer at the Hospices Civils de Lyon (SMALLHAN). Briefly, adult patients newly diagnosed with lung or head \& neck cancer will be recruited at the time of diagnosis (announcement of diagnosis and consultation).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

NCT01647425

Head and Neck Cancer Lung Cancer

COMPLETED

Lung Cancer Screening Implementation Among Employees at Lyon Hospital

NCT05452200

Lung Cancer

UNKNOWN NA

Initiative in LYon for Lung cAncer Screening Development - Prevalence Study

NCT04240418

Lung Cancer Screening

COMPLETED

Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study

NCT05195385

Lung Cancer Screening

RECRUITING NA

Epidemiological Study to Assess the Prevalence of Lung Cancer

NCT03976804

Lung Cancer Tobacco Atherosclerotic Cardiovascular Event

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung or Head and Neck Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients newly diagnosed with lung cancer or head & neck cancer

Patients newly diagnosed with lung cancer or head \& neck cancer (International Classification of Diseases 10: C76, C34) who undergo front-line treatment and who had at least one episode of smoking within the past 30 days before diagnosis

questionnaire

Intervention Type OTHER

A trained interviewer (Clinical Research Associate : CRA) will administer a questionnaire soon after the diagnosis on the phone (within 15 calendar days after diagnosis). The participants are followed up during the first year following the diagnosis through 3 follow-up assessments (at 3, 6, and 12 months after the baseline assessment) and hospital record reviews. At each follow-up, a brief questionnaire will be administered by an interviewer (CRA) via telephone.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire

A trained interviewer (Clinical Research Associate : CRA) will administer a questionnaire soon after the diagnosis on the phone (within 15 calendar days after diagnosis). The participants are followed up during the first year following the diagnosis through 3 follow-up assessments (at 3, 6, and 12 months after the baseline assessment) and hospital record reviews. At each follow-up, a brief questionnaire will be administered by an interviewer (CRA) via telephone.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tabacco and alcohol questionnaires

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients newly diagnosed with lung cancer or head \& neck cancer (International Classification of Diseases 10: C76, C34)
* Patients who undergo front-line treatment
* Age 18 years or older
* Benefiting from a Social Security scheme
* Written information about the study provided to the patient before any procedure specific to the study
* Patients who had at least one episode of smoking within the past 30 days before diagnosis

Exclusion Criteria

* History of another lung or head \& neck cancer \< 5 years (Note: The presence of a second tumour location, discovered at the same time as the lung or head and neck cancer, does not constitute a non-inclusion criterion)
* History of another cancer (except for curatively treated cervical cancer in situ and non-melanoma skin cancer) \< 3 years
* Mesothelioma, thymic malignancies, and cancer of the upper oesophagus
* Inability to complete the study for psychosocial reasons (inability to schedule interview (homeless), no access to phone, psychological disorder leading to inability to answer phone interview, do not speak French and no easy access to translator from surroundings)
* Patient under guardianship
* Patient refusal

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No